Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

LAAO Versus NOAC in Patients with AF and PCI — Stella

Home/Atrial Fibrillation/LAAO Versus NOAC in Patients with AF and PCI

View on ClinicalTrials.gov

Recruiting

Back to Atrial Fibrillation trials

LAAO Versus NOAC in Patients with AF and PCI

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Ling Tao, Xi'an, Shannxi

Key details

Sponsor

Xijing Hospital

Enrollment target

~1,386 participants

Started

September 2022

Primary completion

September 2028

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.